GlyTech Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 26

Employees

  • Latest Deal Type
  • M&A

GlyTech General Information

Description

Developer of biopharmaceutical products designed to prepare purified and characterized human-type N-glycan. The company's products are natural glycoproteins and glycopeptides that are produced through glycoscience and chemical synthetic methods, enabling researchers to contribute to the advancement of human health and help them expand their glycoscience research fields, drug development options, and biotherapeutic analysis capabilities.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 134, Chudoji Minamimachi
  • KRP Number 1-2 Floor, Shimogyo-ku
  • Kyoto, 600-8813
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Parent Company
Vertical(s)
Corporate Office
  • 134, Chudoji Minamimachi
  • KRP Number 1-2 Floor, Shimogyo-ku
  • Kyoto, 600-8813
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlyTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Aug-2024 Completed Generating Revenue
6. Later Stage VC 01-Nov-2022 Completed Generating Revenue
5. Accelerator/Incubator 20-Oct-2021 Completed Generating Revenue
4. Later Stage VC (Series A) 28-May-2018 Completed Generating Revenue
3. Early Stage VC (Series A) 31-Jan-2014 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 02-Apr-2012 Completed Startup
To view GlyTech’s complete valuation and funding history, request access »

GlyTech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C preferred
B preferred
A preferred 1,099,910 $3.74 $3.74 1x $3.74 21.12%
To view GlyTech’s complete cap table history, request access »

GlyTech Patents

GlyTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025234425-A1 Novel peptide derivative and use thereof Pending 08-May-2024
EP-4741410-A1 Solubilization group for poorly water-soluble proteins Pending 06-Jul-2023
WO-2025009591-A1 Solubilization group for poorly water-soluble proteins Inactive 06-Jul-2023
EP-4671376-A1 Protein recognizing k-ras gene mutation cancer Pending 20-Feb-2023
WO-2024176961-A1 Protein recognizing k-ras gene mutation cancer Inactive 20-Feb-2023 A61P35/00
To view GlyTech’s complete patent history, request access »

GlyTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlyTech Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chushin Venture Capital Corporate Venture Capital Minority
DBJ Capital Corporate Venture Capital Minority
Fushimi Pharmaceutical Corporation Minority
J-Startup Accelerator/Incubator
KH Neochem Corporation Minority
You’re viewing 5 of 14 investors. Get the full list »

GlyTech FAQs

  • When was GlyTech founded?

    GlyTech was founded in 2012.

  • Where is GlyTech headquartered?

    GlyTech is headquartered in Kyoto, Japan.

  • What is the size of GlyTech?

    GlyTech has 26 total employees.

  • What industry is GlyTech in?

    GlyTech’s primary industry is Biotechnology.

  • Is GlyTech a private or public company?

    GlyTech is a Private company.

  • What is GlyTech’s current revenue?

    The current revenue for GlyTech is .

  • How much funding has GlyTech raised over time?

    GlyTech has raised $21.4M.

  • Who are GlyTech’s investors?

    Chushin Venture Capital, DBJ Capital, Fushimi Pharmaceutical, J-Startup, and KH Neochem are 5 of 14 investors who have invested in GlyTech.

  • When was GlyTech acquired?

    GlyTech was acquired on 01-Aug-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process